Lung Ultrasound Score Has Better Diagnostic Ability Than NT-proBNP to Predict Moderate-severe Bronchopulmonary Dysplasia

Overview

Journal Eur J Pediatr

Specialty Pediatrics

Date 2022 Jun 1

PMID 35648231

Authors

Almudena Alonso-Ojembarrena

Paula Mendez-Abad

Paula Alonso-Quintela

Pamela Zafra-Rodriguez

Ignacio Oulego-Erroz

Simon P Lubian-Lopez

Affiliations

Soon will be listed here.

Abstract

Conclusion: The LUS score is a better predictor of msBPD on the 7th DOL than NT-proBNP in preterm infants born before 32 weeks, although they have similar diagnostic accuracy on the 1st, 3rd, and 14th DOL. Neither of them, nor together, have a better AUC for msBPD than a clinical model with birthweight and the need for IMV at the 7th DOL.

What Is Known: • NT-proBNP and LUS score are early predictors of moderate-severe bronchopulmonary dysplasia (msBPD).

What Is New: • The combination of both NT-proBNP and LUS score does not increase the predictive ability of each separately.

Citing Articles

Predictive analytics in bronchopulmonary dysplasia: past, present, and future.

McOmber B, Moreira A, Kirkman K, Acosta S, Rusin C, Shivanna B Front Pediatr. 2024; 12:1483940.

PMID: 39633818 PMC: 11615574. DOI: 10.3389/fped.2024.1483940.

Comparison of different types of ultrasound probes for lung ultrasound in neonates-A prospective randomized comparison study.

Aichhorn L, Habrina L, Werther T, Berger A, Kung E PLoS One. 2024; 19(7):e0306472.

PMID: 38959257 PMC: 11221702. DOI: 10.1371/journal.pone.0306472.

Machine learning predictive models for grading bronchopulmonary dysplasia: umbilical cord blood IL-6 as a biomarker.

Gao L, Yang P, Luo C, Lei M, Shi Z, Cheng X Front Pediatr. 2024; 11:1301376.

PMID: 38161441 PMC: 10757373. DOI: 10.3389/fped.2023.1301376.

Prognostic Relevance of the Lung Ultrasound Score: A Multioutcome Study in Infants with Respiratory Distress Syndrome.

Szymanski P, Puskarz-Gasowska J, Hozejowski R, Stefanska M, Blaz W, Sadowska-Krawczenko I Am J Perinatol. 2023; 41(S 01):e2862-e2869.

PMID: 37848043 PMC: 11150063. DOI: 10.1055/s-0043-1775975.

N-Terminal Pro-B Type Natriuretic Peptide as a Predictive Biomarker of Bronchopulmonary Dysplasia or Death Due to Bronchopulmonary Dysplasia in Preterm Neonates: A Systematic Review and Meta-Analysis.

Rodolaki K, Pergialiotis V, Sapantzoglou I, Theodora M, Antsaklis P, Pappa K J Pers Med. 2023; 13(9).

PMID: 37763055 PMC: 10532602. DOI: 10.3390/jpm13091287.

References

Coalson J . Pathology of new bronchopulmonary dysplasia. Semin Neonatol. 2003; 8(1):73-81. DOI: 10.1016/s1084-2756(02)00193-8. View

Zafra-Rodriguez P, Mendez-Abad P, Lubian-Lopez S, Benavente-Fernandez I . NT-proBNP as an Early Marker of Diastolic Ventricular Dysfunction in Very-Low-Birth-Weight Infants. Pediatr Cardiol. 2019; 40(6):1165-1170. DOI: 10.1007/s00246-019-02125-z. View

Dasgupta S, Aly A, Malloy M, Okorodudu A, Jain S . NTproBNP as a surrogate biomarker for early screening of pulmonary hypertension in preterm infants with bronchopulmonary dysplasia. J Perinatol. 2018; 38(9):1252-1257. DOI: 10.1038/s41372-018-0164-1. View

Montaner A, Pinillos R, Galve Z, Boix H, Ruiz de la Cuesta C, Jimenez L . Brain Natriuretic Propeptide as an Early Marker of Bronchopulmonary Dysplasia or Death in the Preterm Newborn. Klin Padiatr. 2017; 229(4):223-228. DOI: 10.1055/s-0043-111597. View

Mir T, Laux R, Hellwege H, Liedke B, Heinze C, von Buelow H . Plasma concentrations of aminoterminal pro atrial natriuretic peptide and aminoterminal pro brain natriuretic peptide in healthy neonates: marked and rapid increase after birth. Pediatrics. 2003; 112(4):896-9. DOI: 10.1542/peds.112.4.896. View

Rodriguez-Blanco S, Oulego-Erroz I, Alonso-Quintela P, Terroba-Seara S, Jimenez-Gonzalez A, Palau-Benavides M . N-terminal-probrain natriuretic peptide as a biomarker of moderate to severe bronchopulmonary dysplasia in preterm infants: A prospective observational study. Pediatr Pulmonol. 2018; 53(8):1073-1081. DOI: 10.1002/ppul.24053. View

Harris S, More K, Dixon B, Troughton R, Pemberton C, Horwood J . Factors affecting N-terminal pro-B-type natriuretic peptide levels in preterm infants and use in determination of haemodynamic significance of patent ductus arteriosus. Eur J Pediatr. 2018; 177(4):521-532. DOI: 10.1007/s00431-018-3089-y. View

Sellmer A, Hjortdal V, Bjerre J, Schmidt M, McNamara P, Bech B . N-Terminal Pro-B Type Natriuretic Peptide as a Marker of Bronchopulmonary Dysplasia or Death in Very Preterm Neonates: A Cohort Study. PLoS One. 2015; 10(10):e0140079. PMC: 4599729. DOI: 10.1371/journal.pone.0140079. View

10.

Corsini I, Parri N, Gozzini E, Coviello C, Leonardi V, Poggi C . Lung Ultrasound for the Differential Diagnosis of Respiratory Distress in Neonates. Neonatology. 2018; 115(1):77-84. DOI: 10.1159/000493001. View

11.

Brat R, Yousef N, Klifa R, Reynaud S, Aguilera S, De Luca D . Lung Ultrasonography Score to Evaluate Oxygenation and Surfactant Need in Neonates Treated With Continuous Positive Airway Pressure. JAMA Pediatr. 2015; 169(8):e151797. DOI: 10.1001/jamapediatrics.2015.1797. View

12.

Raimondi F, Migliaro F, Corsini I, Meneghin F, Dolce P, Pierri L . Lung Ultrasound Score Progress in Neonatal Respiratory Distress Syndrome. Pediatrics. 2021; 147(4). DOI: 10.1542/peds.2020-030528. View

13.

Oulego-Erroz I, Alonso-Quintela P, Terroba-Seara S, Jimenez-Gonzalez A, Rodriguez-Blanco S . Early assessment of lung aeration using an ultrasound score as a biomarker of developing bronchopulmonary dysplasia: a prospective observational study. J Perinatol. 2020; 41(1):62-68. PMC: 7358564. DOI: 10.1038/s41372-020-0724-z. View

14.

Alonso-Ojembarrena A, Lubian-Lopez S . Lung ultrasound score as early predictor of bronchopulmonary dysplasia in very low birth weight infants. Pediatr Pulmonol. 2019; 54(9):1404-1409. DOI: 10.1002/ppul.24410. View

15.

Walsh M, Yao Q, Gettner P, Hale E, Collins M, Hensman A . Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics. 2004; 114(5):1305-11. DOI: 10.1542/peds.2004-0204. View

16.

Gibbs R, Blanco J, St Clair P, Castaneda Y . Quantitative bacteriology of amniotic fluid from women with clinical intraamniotic infection at term. J Infect Dis. 1982; 145(1):1-8. DOI: 10.1093/infdis/145.1.1. View

17.

Pacora P, Chaiworapongsa T, Maymon E, Kim Y, Gomez R, Yoon B . Funisitis and chorionic vasculitis: the histological counterpart of the fetal inflammatory response syndrome. J Matern Fetal Neonatal Med. 2002; 11(1):18-25. DOI: 10.1080/jmf.11.1.18.25. View

18.

Arlettaz R . Echocardiographic Evaluation of Patent Ductus Arteriosus in Preterm Infants. Front Pediatr. 2017; 5:147. PMC: 5478876. DOI: 10.3389/fped.2017.00147. View

19.

Vandenbroucke J, von Elm E, Altman D, Gotzsche P, Mulrow C, Pocock S . Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med. 2007; 147(8):W163-94. DOI: 10.7326/0003-4819-147-8-200710160-00010-w1. View

20.

Mendez-Abad P, Zafra-Rodriguez P, Lubian-Lopez S, Benavente-Fernandez I . NTproBNP is a useful early biomarker of bronchopulmonary dysplasia in very low birth weight infants. Eur J Pediatr. 2019; 178(5):755-761. DOI: 10.1007/s00431-019-03347-2. View

21.

Zhou L, Xiang X, Wang L, Chen X, Zhu J, Xia H . N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker of Bronchopulmonary Dysplasia or Death in Preterm Infants: A Retrospective Cohort Analysis. Front Pediatr. 2019; 7:166. PMC: 6524726. DOI: 10.3389/fped.2019.00166. View